Nanobiotix S.A. (NBTX)
NASDAQ: NBTX · Real-Time Price · USD
43.55
-0.13 (-0.30%)
Aug 21, 2026, 4:00 PM EDT - Market closed

Nanobiotix Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
2,2521,108148346135289
Market Cap Growth
454.33%646.34%-57.08%156.46%-53.41%-50.20%
Enterprise Value
2,3021,134131382116231
Last Close Price
43.5523.122.877.283.678.10

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
58.8528.95-19.938.6426.4296.13
PB Ratio
--11.17-2.18-169.73-4.669.50
P/TBV Ratio
-----9.50

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
60.1529.63-9.5322.6676.63

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
-1.13-1.13-0.77-27.44-1.971.72
Net Debt / Equity Ratio
-0.50-0.50-0.0213.41-0.44-1.41
Net Debt / EBITDA Ratio
-4.06-4.06-0.021.09-0.270.83
Net Debt / FCF Ratio
-1.25-1.25-0.061.93-0.321.26
Asset Turnover
0.480.48-0.470.060.02
Quick Ratio
1.051.050.991.681.232.38
Current Ratio
1.091.091.041.751.382.53
Return on Equity (ROE)
------96.66%
Return on Assets (ROA)
-10.06%-10.06%-52.89%-19.72%-35.38%-25.00%
Return on Capital Employed (ROCE)
-106.10%-106.10%-804.70%-55.10%-209.40%-72.60%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-1.25%-2.54%-47.53%-12.69%-45.21%-18.47%
FCF Yield
-1.76%-3.60%-14.23%-4.09%-29.48%-11.83%
Buyback Yield / Dilution
-1.17%-1.17%-27.99%-5.96%-0.34%-42.43%
SEC Filings: 10-K · 10-Q